IPO Boutique

Mediwound Ltd. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Mediwound Ltd., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Mediwound Ltd.MDWD -
NASDAQ
$14.00-$16.00 $14.00 $16.005 million3/20/2014
Credit Suisse, Jefferies, BMO Capital Markets
Co-Manager(s):
Oppenheimer & Co.
Health Care
Filing(s):

Filed 2014-02-10



Mediwound Ltd. Quote & Chart - Click for current quote - MDWD

About Mediwound Ltd. (adapted from Mediwound Ltd. prospectus):
They are a fully integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel products to address unmet needs in the fields of severe burns, chronic and other hard-to-heal wounds and connective tissue disorders.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "MDWD" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved